{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:11:11Z","timestamp":1777957871558,"version":"3.51.4"},"reference-count":290,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Acute respiratory distress syndrome (ARDS) and cancer share common pathogenetic mechanisms that involve immune dysregulation and inflammatory responses. Inflammasomes, part of the initial innate immune response to infection and injury, play a pivotal role in both carcinogenesis and ARDS. Here we review the role of inflammasomes in ARDS and cancer and, in doing so, we find a set of commonalities that allow the proposal of a conceptual framework for their potential intersection that could inform therapeutic development for both conditions. We highlight the importance of understanding how chronic inflammation induced by ARDS may create a microenvironment conducive to carcinogenesis and discuss how cancer-related inflammasome activity and therapies, like radiotherapy and immunotherapy, might increase susceptibility to ARDS. This review paves the way for future work to investigate strategies to prevent ARDS development in cancer and to repurpose FDA-approved drugs for these diseases, alongside preventive measures to reduce the risk of one disease in the presence of the other.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1798542","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:17:33Z","timestamp":1777954653000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses"],"prefix":"10.3389","volume":"17","author":[{"given":"Salima","family":"Shebbo","sequence":"first","affiliation":[{"name":"Department of Biomedical Science, College of Health Sciences, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]},{"name":"Department of Basic Medical Sciences, College of Medicine, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]},{"name":"College of Dental Medicine, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa Elsayed","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, College of Health Sciences, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]},{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]},{"name":"Department of Chemistry, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences","place":["Dublin, Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nooralhuda","family":"Alateyah","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, College of Health Sciences, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh H.","family":"Hosseini","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, College of Health Sciences, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Al-Haidose","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, College of Health Sciences, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salam A.","family":"Ramirez","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, College of Health Sciences, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]},{"name":"Department of Basic Medical Sciences, College of Medicine, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Zeidan","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atiyeh M.","family":"Abdallah","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, College of Health Sciences, Qatar University (QU) Health, Qatar University","place":["Doha, Qatar"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2021.05.001","article-title":"The epidemiology of acute respiratory distress syndrome before and after coronavirus disease 2019","volume":"37","author":"Hendrickson","year":"2021","journal-title":"Crit Care Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1803139","article-title":"Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19","volume":"39","author":"Badraoui","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17070893","article-title":"Inhalable nanotechnology-based drug delivery systems for the treatment of inflammatory lung diseases","volume":"17","author":"Mahmoud","year":"2025","journal-title":"Pharmaceutics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-222596","article-title":"Role of inflammasomes in acute respiratory distress syndrome","volume":"80","author":"Flower","year":"2025","journal-title":"Thorax"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203317","article-title":"Therapeutic targeting of NF-\u03baB in acute lung injury: a double-edged sword","volume":"11","author":"Millar","year":"2022","journal-title":"Cells"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2012.ed16","article-title":"The difficulties in cancer treatment","volume":"6","author":"Chakraborty","year":"2012","journal-title":"Ecancermedicalscience"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000006028","article-title":"Elevated plasma interleukin-18 identifies high-risk acute respiratory distress syndrome patients not distinguished by prior latent class analyses using traditional inflammatory cytokines: a retrospective analysis of two randomized clinical trials","volume":"51","author":"Moore","year":"2023","journal-title":"Crit Care Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07050-7","article-title":"ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies","volume":"49","author":"Grasselli","year":"2023","journal-title":"Intensive Care Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01107-9","article-title":"Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis","volume":"20","author":"Oh","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-16-0269","article-title":"Inflammasomes and cancer","volume":"5","author":"Karki","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.610492","article-title":"Role of the NLRP3 inflammasome: insights into cancer hallmarks","volume":"11","author":"Lin","year":"2020","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13046-025-03366-y","article-title":"Role of inflammasomes in cancer immunity: mechanisms and therapeutic potential","volume":"44","author":"Singh","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1418290","DOI":"10.1101\/2024.02.05.579000","article-title":"NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns","volume":"15","author":"Wei","year":"2024","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13406","article-title":"Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis","volume":"329","author":"Pandey","year":"2025","journal-title":"Immunol Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41420-024-01978-5","article-title":"The role of IFI16 in regulating PANoptosis and implication in heart diseases","volume":"10","author":"Chang","year":"2024","journal-title":"Cell Death Discov"},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1056\/nejm199605303342209","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)01485-4","article-title":"Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes","volume":"400","author":"Bos","year":"2022","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.797252","article-title":"Right ventricular function in acute respiratory distress syndrome: impact on outcome, respiratory strategy and use of veno-venous extracorporeal membrane oxygenation","volume":"12","author":"Petit","year":"2021","journal-title":"Front Physiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98178","article-title":"Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury","volume":"3","author":"Lefran\u00e7ais","year":"2018","journal-title":"JCI Insight"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1683996","article-title":"Pathogenesis of acute respiratory distress syndrome","volume":"40","author":"Huppert","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/0885066619855021","article-title":"Acute respiratory distress syndrome: etiology, pathogenesis, and summary on management","volume":"35","author":"Kaku","year":"2020","journal-title":"J Intensive Care Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1378\/chest.13-3028","article-title":"Characteristics and outcomes of patients hospitalized following pulmonary aspiration","volume":"146","author":"Lee","year":"2014","journal-title":"Chest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2018.07.002","article-title":"National incidence rates for acute respiratory distress syndrome (ARDS) and ARDS cause-specific factors in the United States (2006-2014)","volume":"47","author":"Eworuke","year":"2018","journal-title":"J Crit Care"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206680","article-title":"Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS)","volume":"70","author":"Dancer","year":"2015","journal-title":"Thorax"},{"key":"B29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2823","article-title":"The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation","volume":"15","author":"Tiruppathi","year":"2014","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116836","article-title":"Chinese medicine as a therapeutic option for pulmonary fibrosis: clinical efficacies and underlying mechanisms","volume":"318","author":"Hao","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24044004","article-title":"Fibrosis: types, effects, markers, mechanisms for disease progression, and its relation with oxidative stress, immunity, and inflammation","volume":"24","author":"Antar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12931-024-02678-5","article-title":"Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS)","volume":"25","author":"Huang","year":"2024","journal-title":"Respir Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.5099\/aj120100060","article-title":"Therapeutic role of surfactant during mitochondrial membrane mediated apoptosis in endotoxin induced acute respiratory distress syndrome","volume":"4","author":"Mittal","year":"2012","journal-title":"Am J BioMed Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05552.x","article-title":"Oxidative stress: acute and progressive lung injury","volume":"1203","author":"Ward","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature07203","article-title":"From endoplasmic-reticulum stress to the inflammatory response","volume":"454","author":"Zhang","year":"2008","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120915","article-title":"Diacerein attenuate LPS-induced acute lung injury via inhibiting ER stress and apoptosis: impact on the crosstalk between SphK1\/S1P, TLR4\/NF\u03baB\/STAT3, and NLRP3\/IL-1\u03b2 signaling pathways","volume":"308","author":"Youssef","year":"2022","journal-title":"Life Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/srep41363","article-title":"Cold-inducible RNA-binding protein (CIRP) causes sepsis-associated acute lung injury via induction of endoplasmic reticulum stress","volume":"7","author":"Khan","year":"2017","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.toxlet.2017.02.023","article-title":"4-PBA inhibits LPS-induced inflammation through regulating ER stress and autophagy in acute lung injury models","volume":"271","author":"Zeng","year":"2017","journal-title":"Toxicol Lett"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2019.1241","article-title":"Roles of endoplasmic reticulum stress in immune responses","volume":"41","author":"So","year":"2018","journal-title":"Mol Cells"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18010064","article-title":"Current concepts of ARDS: a narrative review","volume":"18","author":"Umbrello","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2016.113","article-title":"Neutrophilic NLRP3 inflammasome-dependent IL-1\u03b2 secretion regulates the \u03b3\u03b4T17 cell response in respiratory bacterial infections","volume":"10","author":"Hassane","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir846","article-title":"Staphylococcus aureus \u03b1-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome","volume":"205","author":"Kebaier","year":"2012","journal-title":"J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.188.supp.118.1","article-title":"Cutting edge: IL-1\u03b2 processing during Pseudomonas aeruginosa infection is mediated by neutrophil serine proteases and is independent of NLRC4 and caspase-1","volume":"189","author":"Karmakar","year":"2012","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2019.110661","article-title":"AMPK as a potential pharmacological target for alleviating LPS-induced acute lung injury partly via NLRC4 inflammasome pathway inhibition","volume":"125","author":"He","year":"2019","journal-title":"Exp Gerontol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200195","article-title":"NLRC4 inflammasome-mediated production of IL-1\u03b2 modulates mucosal immunity in the lung against gram-negative bacterial infection","volume":"188","author":"Cai","year":"2012","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108652","article-title":"Influenza infection, SARS, MERS and COVID-19: cytokine storm - the common denominator and the lessons to be learned","volume":"223","author":"Ryabkova","year":"2021","journal-title":"Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41577-021-00588-x","article-title":"Inflammasome activation at the crux of severe COVID-19","volume":"21","author":"Vora","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/2197-425x-1-8","article-title":"IL-1\u03b2 processing in mechanical ventilation-induced inflammation is dependent on neutrophil factors rather than caspase-1","volume":"1","author":"Timmermans","year":"2013","journal-title":"Intensive Care Med Exp"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/aln.0b013e3182518bc0","article-title":"Ventilator-induced lung injury is mediated by the NLRP3 inflammasome","volume":"116","author":"Kuipers","year":"2012","journal-title":"Anesthesiology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175047","article-title":"Fudosteine attenuates acute lung injury in septic mice by inhibiting pyroptosis via the TXNIP\/NLRP3\/GSDMD pathway","volume":"926","author":"He","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12971","article-title":"Inflammasome gene profile is modulated in septic patients, with a greater magnitude in non-survivors","volume":"189","author":"Esquerdo","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.micinf.2018.09.001","article-title":"AIM2 senses Brucella abortus DNA in dendritic cells to induce IL-1\u03b2 secretion, pyroptosis and resistance to bacterial infection in mice","volume":"21","author":"Franco","year":"2019","journal-title":"Microbes Infect"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204742","article-title":"Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome","volume":"69","author":"Summers","year":"2014","journal-title":"Thorax"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.709642","article-title":"Incidence and mortality of acute respiratory distress syndrome in patients with burns: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.trsl.2019.11.002","article-title":"NLRP3 inflammasome activity is required for wound healing after burns","volume":"217","author":"Vinaik","year":"2020","journal-title":"Transl Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.immuni.2021.02.004","article-title":"Post-injury immunosuppression and secondary infections are caused by an AIM2 inflammasome-driven signaling cascade","volume":"54","author":"Roth","year":"2021","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.gastro.2019.09.040","article-title":"NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis","volume":"158","author":"Sendler","year":"2020","journal-title":"Gastroenterology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3683","article-title":"NLRC4-mediated pyroptosis was involved in coagulation disorders of acute pancreatitis","volume":"26","author":"Hu","year":"2024","journal-title":"J Gene Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0b013e3182544f6a","article-title":"Acute respiratory distress syndrome after trauma: development and validation of a predictive model","volume":"40","author":"Watkins","year":"2012","journal-title":"Crit Care Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2017.01.005","article-title":"Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury","volume":"290","author":"Lin","year":"2017","journal-title":"Exp Neurol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B67","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12964-024-01775-8","article-title":"IL-1\u03b2-activated PI3K\/AKT and MEK\/ERK pathways coordinately promote induction of partial epithelial-mesenchymal transition","volume":"22","author":"Tabei","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m114.587121","article-title":"Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling","volume":"289","author":"Kuriakose","year":"2014","journal-title":"J Biol Chem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2019.102673","article-title":"Inflammation-induced DNA damage, mutations and cancer","volume":"83","author":"Kay","year":"2019","journal-title":"DNA Repair (Amst)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12095","article-title":"EMT and inflammation: inseparable actors of cancer progression","volume":"11","author":"Suarez-Carmona","year":"2017","journal-title":"Mol Oncol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-801238-3.65801-4","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1195572","article-title":"The roles of inflammasomes in cancer","volume":"14","author":"Deng","year":"2023","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.07.035","article-title":"Inflammation and cancer","volume":"18","author":"Bhatelia","year":"2019","journal-title":"Ann Afr Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/cells14070488","article-title":"The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis","volume":"14","author":"Nishida","year":"2025","journal-title":"Cells"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1515\/rjim-2016-0025","article-title":"Helicobacter pylori infection, gastric cancer and gastropanel","volume":"54","author":"Loor","year":"2016","journal-title":"Rom J Intern Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02048","article-title":"HBV-induced immune imbalance in the development of HCC","volume":"10","author":"Chen","year":"2019","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01132","article-title":"Inflammasomes and cancer: the dynamic role of the inflammasome in tumor development","volume":"8","author":"Kantono","year":"2017","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12964-023-01235-9","article-title":"Divergent functions of NLRP3 inflammasomes in cancer: a review","volume":"21","author":"Shadab","year":"2023","journal-title":"Cell Commun Signaling"},{"key":"B82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s13238-013-0001-4","article-title":"Inflammasomes in cancer: a double-edged sword","volume":"5","author":"Kolb","year":"2014","journal-title":"Protein Cell"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.374","article-title":"Pyroptosis and inflammasomes in cancer and inflammation","volume":"4","author":"Wang","year":"2023","journal-title":"MedComm (2020)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.492","article-title":"Pyroptosis, metabolism, and tumor immune microenvironment","volume":"11","author":"Du","year":"2021","journal-title":"Clin Transl Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/srep36107","article-title":"Targeting inflammasome\/IL-1 pathways for cancer immunotherapy","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.03.003","article-title":"The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis","volume":"32","author":"Zaki","year":"2010","journal-title":"Immunity"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152737","article-title":"The association of aberrant expression of NLRP3 and p-S6K1 in colorectal cancer","volume":"216","author":"Wang","year":"2020","journal-title":"Pathol Res Pract"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.7150\/jca.101285","article-title":"NLRP3 promotes the proliferation and metastasis of colorectal cancer by regulating the S6K1-GLI1 signaling pathway","volume":"16","author":"Li","year":"2025","journal-title":"J Cancer"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20210280","article-title":"Low NLRP3 expression predicts a better prognosis of colorectal cancer","volume":"41","author":"Shi","year":"2021","journal-title":"Biosci Rep"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116167","article-title":"Inflammasomes are influenced by epigenetic and autophagy mechanisms in colorectal cancer signaling","volume":"25","author":"M\u0171zes","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.trsl.2022.09.002","article-title":"Inflammasome signaling in colorectal cancer","volume":"252","author":"Sharma","year":"2023","journal-title":"Transl Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189271","article-title":"Regulation of NLRP3\/TRIM family signaling in gut inflammation and colorectal cancer","volume":"1880","author":"Mohapatra","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-20-1043","article-title":"Overproduction of gastrointestinal 5-HT promotes colitis-associated colorectal cancer progression via enhancing NLRP3 inflammasome activation","volume":"9","author":"Li","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-22-1136","article-title":"Porphyromonas gingivalis promotes colorectal carcinoma by activating the hematopoietic NLRP3 inflammasome","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123500","article-title":"Prognostic role of inflammasome components in human colorectal cancer","volume":"12","author":"Domblides","year":"2020","journal-title":"Cancers"},{"key":"B96","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1038\/s41467-024-49549-7","article-title":"NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"key":"B97","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s12885-018-4403-9","article-title":"NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.722797","article-title":"Periodontal pathogens promote oral squamous cell carcinoma by regulating ATR and NLRP3 inflammasome","volume":"11","author":"Yao","year":"2021","journal-title":"Front Oncol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12105-024-01685-8","article-title":"Unravelling the significance of NLRP3 and IL-\u03b21 in oral squamous cell carcinoma and potentially Malignant oral disorders: a diagnostic and prognostic exploration","volume":"18","author":"Jain","year":"2024","journal-title":"Head Neck Pathol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26331","article-title":"MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3","volume":"233","author":"Feng","year":"2018","journal-title":"J Cell Physiol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10317","article-title":"ASC contributes to metastasis of oral cavity squamous cell carcinoma","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"B102","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41419-020-02927-7","article-title":"ASC modulates HIF-1\u03b1 stability and induces cell mobility in OSCC","volume":"11","author":"Wu","year":"2020","journal-title":"Cell Death Dis"},{"key":"B103","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-017-0553-x","article-title":"The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma","volume":"36","author":"Feng","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03357-4","article-title":"NLRP3 in tumor-associated macrophages predicts a poor prognosis and promotes tumor growth in head and neck squamous cell carcinoma","volume":"72","author":"Chen","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102796","article-title":"Therapeutic potential of BAY-117082, a selective NLRP3 inflammasome inhibitor, on metastatic evolution in human oral squamous cell carcinoma (OSCC)","volume":"15","author":"Casili","year":"2023","journal-title":"Cancers"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/jmp5020011","article-title":"Mechanisms of inflammasome activation and involvement in liver disease","volume":"5","author":"Baral","year":"2024","journal-title":"J Mol Pathol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"101772","DOI":"10.1016\/j.aohep.2024.101772","article-title":"The role of inflammasomes in hepatocellular carcinoma: mechanisms and therapeutic insights","volume":"30","author":"Arr\u00e8","year":"2025","journal-title":"Ann Hepatol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110107","article-title":"Role of NLRP3 inflammasome in hepatocellular carcinoma: a double-edged sword","volume":"118","author":"Tang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-80962-1_61-1","article-title":"The role of inflammasome in cancers and potential therapeutic targets","volume-title":"Handbook of cancer and immunology","author":"Farhangnia","year":"2022"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm (2020)"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1150325","article-title":"The role of NLRP3 inflammasome in hepatocellular carcinoma","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Pharmacol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200809-100th","article-title":"Smoking and lung cancer: the role of inflammation","volume":"5","author":"Walser","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.05.024","article-title":"Air pollution and lung cancer: a review by International Association for the Study of Lung Cancer Early Detection and Screening Committee","volume":"18","author":"Berg","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B115","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12931-023-02331-7","article-title":"Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury","volume":"24","author":"Rao","year":"2023","journal-title":"Respir Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010193","article-title":"Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS\/NF-\u03baB\/NLRP3\/GSDMD signal axis in non-small cell lung cancer","volume":"12","author":"Teng","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316556","article-title":"NLRP3 inflammasome involvement in heart, liver, and lung diseases-a lesson from cytokine storm syndrome","volume":"24","author":"Napodano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179394","article-title":"Links between infections, lung cancer, and the immune system","volume":"22","author":"Budisan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2023.14","article-title":"Inflammasomes in breast cancer: the ignition spark of progression and resistance","volume":"25","author":"Elgohary","year":"2023","journal-title":"Expert Rev Mol Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12929-021-00724-8","article-title":"NLRP3 inflammasome-mediated cytokine production and pyroptosis\u00a0cell death in breast cancer","volume":"28","author":"Faria","year":"2021","journal-title":"J BioMed Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.60292","article-title":"Cisplatin induces pyroptosis via activation of MEG3\/NLRP3\/caspase-1\/GSDMD pathway in triple-negative breast cancer","volume":"17","author":"Yan","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B122","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12931-023-02491-6","article-title":"Oral bacterial composition associated with lung function and lung inflammation in a community-based Norwegian population","volume":"24","author":"Shigdel","year":"2023","journal-title":"Respir Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.07332","article-title":"The oral-lung axis: the impact of oral health on lung health","volume":"65","author":"Gaeckle","year":"2020","journal-title":"Respir Care"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/app12168213","article-title":"Oral-systemic health and disorders: latest advances on oral\u2013gut\u2013lung microbiome axis","volume":"12","author":"Amato","year":"2022","journal-title":"Appl Sci"},{"key":"B125","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1038\/s41598-024-56849-x","article-title":"Defining Porphyromonas gingivalis strains associated with periodontal disease","volume":"14","author":"Murugaiyan","year":"2024","journal-title":"Sci Rep"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2021.104925","article-title":"Porphyromonas gingivalis in oral squamous cell carcinoma: a review","volume":"24","author":"Singh","year":"2022","journal-title":"Microbes Infect"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102494","article-title":"Oral administration of Porphyromonas gingivalis, a major pathogen of chronic periodontitis, promotes resistance to paclitaxel in mouse xenografts of oral squamous cell carcinoma","volume":"20","author":"Song","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16550","article-title":"Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential","volume":"8","author":"Woo","year":"2017","journal-title":"Oncotarget"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113433","article-title":"Exposure to Porphyromonas gingivalis induces production of proinflammatory cytokine via TLR2 from human respiratory epithelial cells","volume":"9","author":"Watanabe","year":"2020","journal-title":"J Clin Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1626243","article-title":"Unravelling molecular mechanism of oral squamous cell carcinoma and genetic landscape: an insight into disease complexity, available therapies, and future considerations","volume":"16","author":"Shebbo","year":"2025","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118114","article-title":"Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: role of lncRNAs in cytokine storm modulation","volume":"257","author":"Paniri","year":"2020","journal-title":"Life Sci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1353012","article-title":"Alveolar cytokines and interferon autoantibodies in COVID-19 ARDS","volume":"15","author":"Jonassen","year":"2024","journal-title":"Front Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1243727","article-title":"Suppression of inflammation-induced lung cancer cells proliferation and metastasis by exiguaflavanone A and exiguaflavanone B from Sophora exigua root extract through NLRP3 inflammasome pathway inhibition","volume":"14","author":"Arjsri","year":"2023","journal-title":"Front Pharmacol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13046-022-02376-4","article-title":"Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2\/STAT3\/Sox4\/NLRP3 signaling pathway","volume":"41","author":"Xiao","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s464838","article-title":"Acute lung injury and the NLRP3 inflammasome","volume":"17","author":"Gu","year":"2024","journal-title":"J Inflammation Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01687-y","article-title":"The role of inflammasomes in human diseases and their potential as therapeutic targets","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B137","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s43556-025-00337-9","article-title":"Neutrophil extracellular traps (NETs) in health and disease","volume":"6","author":"Shahzad","year":"2025","journal-title":"Mol BioMed"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031464","article-title":"A narrative review: the role of NETs in acute respiratory distress syndrome\/acute lung injury","volume":"25","author":"Zhou","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867516","article-title":"Neutrophil extracellular traps (NETs) promote non-small cell lung cancer metastasis by suppressing lncRNA MIR503HG to activate the NF-\u03baB\/NLRP3 inflammasome pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s44424-025-00014-2","article-title":"The inflammasome-NETosis axis: a critical pathway in atherosclerosis pathogenesis and therapeutic targeting","volume":"18","author":"Park","year":"2025","journal-title":"Innov Acupuncture Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1042\/cs20180600","article-title":"NLRP3 activation induced by neutrophil extracellular traps sustains inflammatory response in the diabetic wound","volume":"133","author":"Liu","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02590-2017","article-title":"Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS","volume":"52","author":"Gr\u00e9goire","year":"2018","journal-title":"Eur Respir J"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202388","article-title":"Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages","volume":"190","author":"Kahlenberg","year":"2013","journal-title":"J Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s44276-023-00022-w","article-title":"Metformin may improve the outcome of patients with colorectal cancer and type 2 diabetes mellitus partly through effects on neutrophil extracellular traps","volume":"1","author":"Saito","year":"2023","journal-title":"BJC Rep"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155926","article-title":"The multi-herbal decoction SH003 alleviates LPS-induced acute lung injury by targeting inflammasome and extracellular traps in neutrophils","volume":"133","author":"Kim","year":"2024","journal-title":"Phytomedicine"},{"key":"B149","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00011-023-01822-z","article-title":"Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by stimulating the release of neutrophil extracellular traps in the tumor immune microenvironment","volume":"73","author":"Guo","year":"2024","journal-title":"Inflammation Res"},{"key":"B150","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41420-024-01982-9","article-title":"Neutrophil extracellular traps promote invasion and metastasis via NLRP3-mediated oral squamous cell carcinoma pyroptosis inhibition","volume":"10","author":"Zhai","year":"2024","journal-title":"Cell Death Discov"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-115737","article-title":"Neutrophil extracellular traps enhance procoagulant activity in patients with oral squamous cell carcinoma","volume":"145","author":"Li","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c11280","article-title":"Nanoparticulate cationic poly(amino acid)s block cancer metastases by destructing neutrophil extracellular traps","volume":"17","author":"Liang","year":"2023","journal-title":"ACS Nano"},{"key":"B153","doi-asserted-by":"publisher","first-page":"798","DOI":"10.17305\/bb.2023.10101","article-title":"The link between neutrophils, NETs, and NLRP3 inflammasomes: The dual effect of CD177 and its therapeutic potential in acute respiratory distress syndrome\/acute lung injury","volume":"24","author":"Li","year":"2024","journal-title":"Biomol BioMed"},{"key":"B154","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41420-022-01166-3","article-title":"Neutrophil extracellular traps-triggered impaired autophagic flux via METTL3 underlies sepsis-associated acute lung injury","volume":"8","author":"Qu","year":"2022","journal-title":"Cell Death Discov"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s321513","article-title":"Neutrophil extracellular traps augmented alveolar macrophage pyroptosis via AIM2 inflammasome activation in LPS-induced ALI\/ARDS","volume":"14","author":"Li","year":"2021","journal-title":"J Inflammation Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.714357","article-title":"The role of neutrophil extracellular traps in cancer","volume":"11","author":"Shao","year":"2021","journal-title":"Front Oncol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00189-25","article-title":"Mechanisms and immune crosstalk of neutrophil extracellular traps in response to infection","volume":"16","author":"Liu","year":"2025","journal-title":"mBio"},{"key":"B158","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40364-023-00463-y","article-title":"Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target","volume":"11","author":"Shang","year":"2023","journal-title":"biomark Res"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019103397","article-title":"Beyond inflammasomes: emerging function of gasdermins during apoptosis and NETosis","volume":"39","author":"Chen","year":"2020","journal-title":"EMBO J"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.001","article-title":"NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps","volume":"41","author":"Adrover","year":"2023","journal-title":"Cancer Cell"},{"key":"B162","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-023-01407-7","article-title":"Involvement of inflammasomes in tumor microenvironment and tumor therapies","volume":"16","author":"Zhang","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"108545","DOI":"10.2139\/ssrn.4501298","article-title":"NLRP3 and cancer: Pathogenesis and therapeutic opportunities","volume":"251","author":"Tengesdal","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413689","article-title":"Therapeutic significance of NLRP3 inflammasome in cancer: Friend or foe","volume":"25","author":"Jalali","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2021.203.1_meetingabstracts.a2675","article-title":"Cancer is an independent risk factor for acute respiratory distress syndrome in critically ill patients: A single center retrospective cohort study","volume":"37","author":"Ho","year":"2022","journal-title":"J Intensive Care Med"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3354-0","article-title":"Acute respiratory distress syndrome in patients with Malignancies","volume":"40","author":"Azoulay","year":"2014","journal-title":"Intensive Care Med"},{"key":"B167","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13613-024-01373-4","article-title":"Acute respiratory distress syndrome in patients with hematological Malignancies: a one-year retrospective nationwide cohort study","volume":"14","author":"Bris","year":"2024","journal-title":"Ann Intensive Care"},{"key":"B168","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00075198-200202000-00002","article-title":"Role of reactive oxygen and nitrogen species in acute respiratory distress syndrome","volume":"8","author":"Fink","year":"2002","journal-title":"Curr Opin Crit Care"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.immuni.2021.05.004","article-title":"Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation","volume":"54","author":"Xian","year":"2021","journal-title":"Immunity"},{"key":"B170","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12951-025-03219-y","article-title":"Promotion of NLRP3 autophagosome degradation by PV-K nanodevice for protection against macrophage pyroptosis-mediated lung injury","volume":"23","author":"Fan","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1038\/s41467-021-25015-6","article-title":"SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation","volume":"12","author":"Pan","year":"2021","journal-title":"Nat Commun"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9152140","article-title":"Caspase-1-dependent pyroptosis of peripheral blood mononuclear cells is associated with the severity and mortality of septic patients","volume":"2020","author":"Wang","year":"2020","journal-title":"BioMed Res Int"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2018.1500180","article-title":"Anticancer therapy and lung injury: molecular mechanisms","volume":"18","author":"Li","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"B174","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1159\/000102692","article-title":"Drug-induced and iatrogenic infiltrative lung disease","volume":"25","author":"Camus","year":"2004","journal-title":"Clin Chest Med"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1093\/toxres\/tfac021","article-title":"Alleviation of chemotherapy-induced acute lung injury via NLRP3\/ ASC\/ Caspase-1 signaling pathway","volume":"11","author":"Sherif","year":"2022","journal-title":"Toxicol Res (Camb)"},{"key":"B176","article-title":"NLRP3 inflammasome induces pyroptosis in lung tissues of radiation-induced lung injury in mice","volume":"33","author":"Han","year":"2017","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.11.079","article-title":"Extracellular ATP activates the NLRP3 inflammasome and is an early danger signal of skin allograft rejection","volume":"21","author":"Amores-Iniesta","year":"2017","journal-title":"Cell Rep"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00352","article-title":"Reactive oxygen species at the crossroads of inflammasome and inflammation","volume":"5","author":"Harijith","year":"2014","journal-title":"Front Physiol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: Current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci"},{"key":"B180","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12964-024-01521-0","article-title":"Exosomes derived from programmed cell death: mechanism and biological significance","volume":"22","author":"Xiong","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.4161\/viru.2.2.15480","article-title":"HMGB1 release by inflammasomes","volume":"2","author":"Vande Walle","year":"2011","journal-title":"Virulence"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109701","article-title":"Acute respiratory distress syndrome enhances tumor metastasis into lungs: Role of BRD4 in the tumor microenvironment","volume":"115","author":"Pooladanda","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.10.024","article-title":"NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma","volume":"497","author":"Lu","year":"2021","journal-title":"Cancer Lett"},{"key":"B184","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-74588-6_48","article-title":"Acute respiratory distress syndrome in cancer patients","volume-title":"Oncologic critical care","author":"Young","year":"2020"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-08113-7","article-title":"Acute respiratory distress syndrome in patients with cancer: the YELENNA prospective multinational observational cohort study","volume":"51","author":"Schellongowski","year":"2025","journal-title":"Intensive Care Med"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13091528","article-title":"Acute respiratory distress syndrome; a review of recent updates and a glance into the future","volume":"13","author":"Ramji","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122390","article-title":"Chronic inflammation and cancer; the two sides of a coin","volume":"338","author":"Fernandes","year":"2024","journal-title":"Life Sci"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-15789","article-title":"Long-term outcomes after ARDS","volume":"22","author":"Lee","year":"2001","journal-title":"Semin Respir Crit Care Med"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2020.1743182","article-title":"The long-lasting effects of the acute respiratory distress syndrome","volume":"14","author":"Mart","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3390\/cells15050480","article-title":"TGF-\u03b2 signaling as a pathological continuum linking idiopathic pulmonary fibrosis and lung cancer","volume":"15","author":"Huang","year":"2026","journal-title":"Cells"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01444","article-title":"NLRP3 inflammasome activation in cancer: A double-edged sword","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Front Immunol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29769","article-title":"The critical impacts of cytokine storms in respiratory disorders","volume":"10","author":"Tramboo","year":"2024","journal-title":"Heliyon"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-025-01532-6","article-title":"Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation","volume":"48","author":"Jang","year":"2025","journal-title":"Arch Pharmacal Res"},{"key":"B194","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12032-017-0913-6","article-title":"Chemotherapy-related acute respiratory distress syndrome in germ cell tumors: a literature review","volume":"34","author":"Alsharedi","year":"2017","journal-title":"Med Oncol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021414","article-title":"How I manage acute respiratory failure in patients with hematological Malignancies","volume":"143","author":"Azoulay","year":"2024","journal-title":"Blood"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(18)30345-x","article-title":"Acute respiratory failure in immunocompromised adults","volume":"7","author":"Azoulay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188049","article-title":"From bench to bedside: the history and progress of CAR T cell therapy","volume":"14","author":"Mitra","year":"2023","journal-title":"Front Immunol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1350208","article-title":"Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy","volume":"15","author":"Shebbo","year":"2024","journal-title":"Front Immunol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1079181","article-title":"Serious adverse events and coping strategies of CAR-T cells in the treatment of Malignant tumors","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"B200","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy \u2014 assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.003","article-title":"Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)","volume":"33","author":"Hayden","year":"2022","journal-title":"Ann Oncol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s1470-2045(14)71170-2","article-title":"Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study","volume":"16","author":"Topp","year":"2015","journal-title":"Lancet Oncol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.06.010","article-title":"Severe cytokine-release syndrome after T cell-replete peripheral blood haploidentical donor transplantation is associated with poor survival and anti-IL-6 therapy is safe and well tolerated","volume":"22","author":"Abboud","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.06.006","article-title":"Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cells","volume":"31","author":"Haas","year":"2023","journal-title":"Mol Ther"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1154","article-title":"Severe delayed pulmonary toxicity following PD-L1-specific CAR-T cell therapy for non-small cell lung cancer","volume":"9","author":"Liu","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06389-5","article-title":"Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks","volume":"15","author":"Meng","year":"2024","journal-title":"Cell Death Dis"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr Oncol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N Engl J Med"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0058-2019","article-title":"Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer","volume":"28","author":"Cadranel","year":"2019","journal-title":"Eur Respir Rev"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2020.05.008","article-title":"Clinical burden of immune checkpoint inhibitor-induced pneumonitis","volume":"58","author":"Sakamoto","year":"2020","journal-title":"Respir Investig"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.68.2005","article-title":"Pneumonitis in patients treated with anti\u2013programmed death-1\/programmed death ligand 1 therapy","volume":"35","author":"Naidoo","year":"2016","journal-title":"J Clin Oncol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.57357","article-title":"Long-term survival by number of immune checkpoint inhibitors in PD-L1-negative metastatic NSCLC: A systematic review and meta-analysis","volume":"8","author":"Ponvilawan","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.03.017","article-title":"Predictors of response, progression-free survival, and overall survival in patients with lung cancer treated with immune checkpoint inhibitors","volume":"16","author":"Memmott","year":"2021","journal-title":"J Thorac Oncol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(24)00040-8","article-title":"Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis","volume":"25","author":"Goulart","year":"2024","journal-title":"Lancet Oncol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0930-7","article-title":"Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome","volume":"123","author":"Pickles","year":"2020","journal-title":"Br J Cancer"},{"key":"B217","doi-asserted-by":"publisher","first-page":"L165","DOI":"10.1152\/ajplung.00303.2020","article-title":"Inflammasome activation in acute lung injury","volume":"320","author":"McVey","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.7554\/elife.52668","article-title":"Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-\u03b1","volume":"9","author":"Tezera","year":"2020","journal-title":"Elife"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02512-2021","article-title":"The paradox of immune checkpoint inhibition re-activating tuberculosis","volume":"60","author":"Mohamed","year":"2022","journal-title":"Eur Respir J"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123550","article-title":"Understanding inflammasomes and PD-1\/PD-L1 crosstalk to improve cancer treatment efficiency","volume":"12","author":"Perrichet","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1172\/jci133055","article-title":"A tumor-intrinsic PD-L1\/NLRP3 inflammasome signaling pathway drives resistance to anti\u2013PD-1 immunotherapy","volume":"130","author":"Theivanthiran","year":"2020","journal-title":"J Clin Invest"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010127","article-title":"Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers","volume":"13","author":"Lu","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int J Med Sci"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(88)90241-6","article-title":"The association of adult respiratory distress syndrome (ARDS) with thoracic irradiation (RT)","volume":"15","author":"Byhardt","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.670464","article-title":"Radiotherapy and cytokine storm: risk and mechanism","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0311-9","article-title":"Cytokine release syndrome after radiation therapy: case report and review of the literature","volume":"6","author":"Barker","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2024.101513","article-title":"Cytokine release syndrome in a patient with metastatic triple-negative breast cancer treated with hypofractionated radiation therapy, who had previously undergone immunotherapy: A case report","volume":"9","author":"Chang","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10113","article-title":"Protective effects of propofol on experimental neonatal acute lung injury","volume":"19","author":"Yu","year":"2019","journal-title":"Mol Med Rep"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1590\/acb361004","article-title":"Effects of propofol on inflammatory response and activation of p38 MAPK signaling pathway in rats with ventilator-induced lung injury","volume":"36","author":"Deng","year":"2021","journal-title":"Acta Cir Bras"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.801337","article-title":"Metformin alleviates LPS-induced acute lung injury by regulating the SIRT1\/NF-\u03baB\/NLRP3 pathway and inhibiting endothelial cell pyroptosis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101345","article-title":"Metformin protects against PM(2.5)-induced lung injury and cardiac dysfunction independent of AMP-activated protein kinase \u03b12","volume":"28","author":"Gao","year":"2020","journal-title":"Redox Biol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.3ma0320-358rr","article-title":"Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS","volume":"108","author":"Liu","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B234","article-title":"Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K\/AKT\/mTOR pathway","volume":"11","author":"Qu","year":"2019","journal-title":"Am J Transl Res"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.04.14","article-title":"Effects of glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model","volume":"11","author":"Lee","year":"2019","journal-title":"J Thorac Dis"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115948","article-title":"Glycyrrhizin mitigates acute lung injury by inhibiting the NLRP3 inflammasome in vitro and in vivo","volume":"303","author":"Wang","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-021-01581-1","article-title":"Emodin Attenuates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis Signaling Pathway In vitro and In vivo","volume":"45","author":"Liu","year":"2022","journal-title":"Inflammation"},{"key":"B238","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12964-019-0366-y","article-title":"Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-\u03baB pathways","volume":"17","author":"Yang","year":"2019","journal-title":"Cell Commun Signal"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.5483\/bmbrep.2016.49.10.115","article-title":"Mitophagy: a balance regulator of NLRP3 inflammasome activation","volume":"49","author":"Kim","year":"2016","journal-title":"BMB Rep"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2021.1948774","article-title":"Sestrin2 in hypoxia and hypoxia-related diseases","volume":"26","author":"Che","year":"2021","journal-title":"Redox Rep"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.890710","article-title":"CaMK4 promotes acute lung injury through NLRP3 inflammasome activation in type II alveolar epithelial cell","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1358","article-title":"The use of glyburide compared with other sulfonylureas and the risk of cancer in patients with type 2 diabetes","volume":"38","author":"Tuccori","year":"2015","journal-title":"Diabetes Care"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-s218","article-title":"Glyburide for the Treatment of Gestational Diabetes: A critical appraisal","volume":"30","author":"Moore","year":"2007","journal-title":"Diabetes Care"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1002\/tox.22919","article-title":"Glyburide attenuates ozone-induced pulmonary inflammation and injury by blocking the NLRP3 inflammasome","volume":"35","author":"Shao","year":"2020","journal-title":"Environ Toxicol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"8457010","DOI":"10.1155\/2022\/8457010","article-title":"Glibenclamide alleviates LPS-induced acute lung injury through NLRP3 inflammasome signaling pathway","volume":"2022","author":"Yang","year":"2022","journal-title":"Mediators Inflammation"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111640","article-title":"Glyburide suppresses inflammation-related colorectal tumorigenesis through inhibition of NLRP3 inflammasome","volume":"25","author":"Maeda","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B247","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2020.01.011","article-title":"Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives","volume":"69","author":"Ali","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1021\/nn203596e","article-title":"Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages","volume":"5","author":"Lunov","year":"2011","journal-title":"ACS Nano"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202509994","article-title":"Proton-driven deformability enables nanozyme-integrated vaccine for enhanced tumor immunotherapy","volume":"38","author":"An","year":"2026","journal-title":"Adv Mater"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-020-00782-3","article-title":"Proton-driven transformable nanovaccine for cancer immunotherapy","volume":"15","author":"Gong","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100050","article-title":"The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer","volume":"207","author":"Allen","year":"2010","journal-title":"J Exp Med"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002046","article-title":"IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation","volume":"185","author":"Zaki","year":"2010","journal-title":"J Immunol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.08.013","article-title":"The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity","volume":"43","author":"Dupaul-Chicoine","year":"2015","journal-title":"Immunity"},{"key":"B254","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41419-025-07578-0","article-title":"A small molecule directly targets NLRP3 to promote inflammasome activation and antitumor immunity","volume":"16","author":"Liu","year":"2025","journal-title":"Cell Death Dis"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012182","article-title":"Macrophage NLRP3 activation and IL-1\u03b2 release drive osimertinib-induced antitumor immunity","volume":"13","author":"Yu","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B256","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12672-024-01361-x","article-title":"Codonopsis pilosula polysaccharide suppresses the progression of non-small cell lung cancer by triggering NLRP3\/GSDMD-dependent pyroptosis","volume":"15","author":"Huang","year":"2024","journal-title":"Discov Oncol"},{"key":"B257","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/labinvest.2013.126","article-title":"Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression","volume":"94","author":"Wei","year":"2014","journal-title":"Lab Invest"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19542","article-title":"Role of NLRP3 inflammasome activation in HCC cell progression","volume":"9","author":"Dai","year":"2023","journal-title":"Heliyon"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2015.63","article-title":"Estrogen suppresses hepatocellular carcinoma cells through ER\u03b2-mediated upregulation of the NLRP3 inflammasome","volume":"95","author":"Wei","year":"2015","journal-title":"Lab Invest"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.3727\/096504018X15462920753012","article-title":"E2-induced activation of the NLRP3 inflammasome triggers pyroptosis and inhibits autophagy in HCC cells","volume":"27","author":"Wei","year":"2019","journal-title":"Oncol Res"},{"key":"B261","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduction Targeted Ther"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01499-z","article-title":"Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial","volume":"27","author":"Kyriazopoulou","year":"2021","journal-title":"Nat Med"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1002\/art.10141","article-title":"Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial","volume":"46","author":"Cohen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"B267","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1200\/JCO.23.00980","article-title":"Canakinumab versus placebo in combination with first-line pembrolizumab plus chemotherapy for advanced non-small-cell lung cancer: Results from the CANOPY-1 trial","volume":"42","author":"Tan","year":"2024","journal-title":"J Clin Oncol"},{"key":"B268","doi-asserted-by":"publisher","first-page":"107451","DOI":"10.1016\/j.lungcan.2023.107451","article-title":"Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial","volume":"189","author":"Paz-Ares","year":"2024","journal-title":"Lung Cancer"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine--update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"B270","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00011-022-01540-y","article-title":"Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation","volume":"71","author":"Bonaventura","year":"2022","journal-title":"Inflammation Res"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00222-8","article-title":"Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial","volume":"9","author":"Tardif","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00299-5","article-title":"Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial","volume":"10","author":"Eikelboom","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1159\/000504759","article-title":"Protective effect of colchicine on LPS-induced lung injury in rats via inhibition of P-38, ERK1\/2, and JNK activation","volume":"105","author":"Yue","year":"2020","journal-title":"Pharmacology"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02578","article-title":"OLT1177 (Dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis","volume":"10","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2019","journal-title":"Front Immunol"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B276","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","article-title":"Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral NLRP3 inhibitor dapansutrile in subjects with NYHA II-III systolic heart failure","volume":"77","author":"Wohlford","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ Res"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2020.8257","article-title":"Loop between NLRP3 inflammasome and reactive oxygen species","volume":"36","author":"Dominic","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"B279","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B280","doi-asserted-by":"publisher","first-page":"17534666231158563","DOI":"10.1177\/17534666231158563","article-title":"The efficacy of N-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis","volume":"17","author":"Huang","year":"2023","journal-title":"Ther Adv Respir Dis"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25179","article-title":"Clinical efficacy of N-acetylcysteine for COVID-19: A systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.1449","article-title":"A double-blind randomized controlled trial of N-acetylcysteine (NAC) for the treatment of acute exacerbation of chronic obstructive pulmonary disease","volume":"12","author":"Kwok","year":"2024","journal-title":"Respirol Case Rep"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401520","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome","volume":"370","author":"Truwit","year":"2014","journal-title":"N Engl J Med"},{"key":"B284","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B285","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1056\/NEJMc2108482","article-title":"Interleukin-6 receptor antagonists in critically ill patients with Covid-19","volume":"385","author":"Brown","year":"2021","journal-title":"N Engl J Med"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"B287","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s42003-026-09524-y","article-title":"Nimbolide ameliorates ARDS and ulcerative colitis by disrupting NLRP3 inflammasome activation","volume":"9","author":"Xu","year":"2026","journal-title":"Commun Biol"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020404","article-title":"Promising targets for cancer immunotherapy: TLRs, RLRs, and STING-mediated innate immune pathways","volume":"18","author":"Li","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00078812","article-title":"Application of 'omics technologies to biomarker discovery in inflammatory lung diseases","volume":"42","author":"Wheelock","year":"2013","journal-title":"Eur Respir J"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1177\/1535370217715441","article-title":"Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective","volume":"242","author":"Ewart","year":"2017","journal-title":"Exp Biol Med (Maywood)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1798542\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:17:36Z","timestamp":1777954656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1798542\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":290,"alternative-id":["10.3389\/fimmu.2026.1798542"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1798542","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"article-number":"1798542"}}